SGMO

#3971
Sangamo Therapeutics, Inc. Common Stock
0.26 USD
0.00%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
0.26
0.26
Range Annuel
0.21
0.84
Changement quotidien
0.00%
Changement Mensuel
-35.00%
Evolution sur 6 mois
-62.86%
Changement Annuel
-65.33%
Clôture Précédente
0.26
Open
0.26
Bid
Ask
Low
0.26
High
0.26
Volume
121
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
  • Market Capitalization 107.71 M
  • Employee 183
  • Founded 1995
  • CEO Sandy Macrae
  • Website www.sangamo.com
  • Headquarter Delaware, United States
  • FIGI BBG000BHYT80
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.95
Price to sales ratio
2.98

Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is an American biotechnology company based in Brisbane, California, that develops cell and gene therapies for severe genetic diseases.

Nouvelles